Amplia Therapeutics Limited
ASX:ATX.AX
0.15 (AUD) • At close October 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2016 Q4 | 2016 Q2 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.004 | 2.448 | -0.58 | 1.769 | 1.221 | 0.763 | 0.674 | 0.86 | 0.034 | 0 | -0 | 0.051 | -0.077 | 0.657 | 0.616 | 1.182 | 1.447 | 0.817 | -0.015 | 0.008 | 0.015 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.331 | 0.043 | 0.044 | 0.029 | 0.002 | 0.002 | 0 | 0 | 0 | 0 | 0.079 | 0.077 | 0.022 | 0.08 | 0.075 | 0.131 | 0.114 | 0.136 | 0.149 | 0 | 0.089 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 1.674 | 2.405 | -0.624 | 1.74 | 1.219 | 0.761 | 0.673 | 0.86 | 0.034 | -0 | -0.079 | -0.026 | -0.1 | 0.577 | 0.541 | 1.051 | 1.332 | 0.681 | -0.164 | 0.008 | -0.074 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.835 | 0.982 | 1.077 | 0.984 | 0.999 | 0.998 | 0.999 | 1 | 0.988 | 0 | 187.19 | -0.511 | 1.291 | 0.878 | 0.879 | 0.889 | 0.921 | 0.834 | 11.07 | 1 | -4.997 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 3.611 | 2.194 | 1.158 | 3.529 | 2.471 | 1.302 | 1.461 | 0.75 | 0.758 | 0.313 | 0.542 | 0.136 | 1.196 | 2.029 | 3.148 | 2.888 | 3.305 | 1.442 | 1.227 | 0.51 | 0.674 | 0.162 | 0.162 | 0.162 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 1.389 | 1.215 | 1.205 | 0.993 | 0.904 | 0.732 | 0.634 | 0.501 | 0.406 | 0.453 | 0.394 | 0.467 | 0.538 | 0.815 | 0.731 | 0.733 | 0.628 | 0.619 | 0.923 | 0.4 | 0.5 | 0.437 | 0.437 | 0.437 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0.04 | 0.158 | 0.388 | 0.128 | 0.165 | 0.05 | 0.351 | 0.177 | 0.205 | 0.122 | 0.147 | 0.097 | 0.034 | 0.158 | 0.144 | 0.153 | 0.142 | 0.129 | 0.14 | 0 | 0.016 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1.429 | 1.373 | 1.594 | 1.121 | 1.069 | 0.782 | 0.985 | 0.678 | 0.611 | 0.575 | 0.541 | 0.564 | 0.575 | 1.045 | 1.049 | 1.641 | 0.852 | 0.895 | 1.225 | -0.451 | 0.516 | -0.107 | -0.107 | -0.107 | 0 | 0 | 0 | 0 |
| Other Expenses
| -0.023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 5.016 | 3.567 | 2.752 | 4.65 | 3.54 | 2.084 | 2.446 | 1.428 | 1.37 | 0.889 | 1.084 | 0.701 | 1.713 | 3.089 | 4.183 | 4.547 | 4.177 | 2.854 | 3.204 | 0.059 | 1.956 | 0.055 | 0.055 | 0.055 | 0 | 0 | 0 | 0 |
| Operating Income
| -3.342 | -3.61 | -2.796 | -4.679 | -3.542 | -2.085 | -2.446 | -1.429 | -1.37 | -0.889 | -1.163 | -0.727 | -1.813 | -2.512 | -3.642 | -3.496 | -2.844 | -2.173 | -3.368 | -1.35 | -2.03 | -1.022 | -1.022 | -1.022 | 0 | 0 | 0 | 0 |
| Operating Income Ratio
| -1.668 | -1.474 | 4.822 | -2.644 | -2.901 | -2.735 | -3.632 | -1.661 | -40.032 | 0 | 2,756.372 | -14.285 | 23.517 | -3.821 | -5.914 | -2.957 | -1.966 | -2.661 | 227.399 | -178.107 | -137.052 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -0.032 | 0.032 | 0.046 | 0.039 | -0.001 | 0 | 0.003 | 0.057 | 0.002 | 0.004 | 0.011 | 0.009 | 0.011 | 0.016 | 0.048 | 0.013 | 0.036 | 0.038 | 0.07 | 0.04 | 0.092 | -0.102 | -0.102 | -0.102 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -3.374 | -3.578 | -2.751 | -4.64 | -3.542 | -2.085 | -2.444 | -1.371 | -1.368 | -0.885 | -1.152 | -0.718 | -1.802 | -2.495 | -3.594 | -3.482 | -2.808 | -2.135 | -3.299 | -1.309 | -1.938 | -1.124 | -1.124 | -1.124 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -1.683 | -1.461 | 4.743 | -2.622 | -2.902 | -2.735 | -3.628 | -1.594 | -39.981 | 0 | 2,730.227 | -14.103 | 23.379 | -3.796 | -5.836 | -2.945 | -1.941 | -2.615 | 222.691 | -172.773 | -130.845 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -1.989 | -2.448 | 0.58 | -1.728 | -1.221 | -0.763 | -0.674 | -0.86 | -0.034 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.04 | 0.04 | 0.022 | 0.022 | 0.022 | 0.022 | 0 | 0 | 0 | 0 |
| Net Income
| -3.374 | -1.129 | -3.331 | -2.912 | -2.322 | -1.323 | -1.77 | -0.511 | -1.334 | -0.885 | -1.152 | -0.718 | -1.802 | -2.495 | -3.594 | -3.482 | -2.808 | -2.135 | -3.299 | -1.309 | -1.938 | -1.124 | -1.124 | -1.124 | 0 | 0 | 0 | 0 |
| Net Income Ratio
| -1.683 | -0.461 | 5.743 | -1.646 | -1.902 | -1.735 | -2.628 | -0.594 | -38.981 | 0 | 2,730.227 | -14.103 | 23.379 | -3.796 | -5.836 | -2.945 | -1.941 | -2.615 | 222.691 | -172.773 | -130.845 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.017 | -0.006 | -0.017 | -0.015 | -0.014 | -0.011 | -0.016 | -0.006 | -0.018 | -0.017 | -0.028 | -0.019 | -0.08 | -0.11 | -0.16 | -0.17 | -0.15 | -0.12 | -0.19 | -0.069 | -0.11 | -0.087 | -0.087 | -0.087 | 0 | 0 | 0 | 0 |
| EPS Diluted
| -0.017 | -0.006 | -0.017 | -0.015 | -0.014 | -0.011 | -0.016 | -0.006 | -0.018 | -0.017 | -0.028 | -0.019 | -0.08 | -0.11 | -0.16 | -0.17 | -0.15 | -0.12 | -0.19 | -0.069 | -0.11 | -0.087 | -0.087 | -0.087 | 0 | 0 | 0 | 0 |
| EBITDA
| -3.441 | -3.567 | -2.752 | -4.65 | -3.54 | -2.084 | -2.446 | -1.428 | -1.37 | -0.889 | -1.162 | -0.726 | -1.808 | -2.496 | -3.622 | -3.478 | -2.793 | -1.656 | -2.586 | -0.922 | -1.264 | -0.632 | -0.632 | -0.632 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| -1.717 | -1.457 | 4.746 | -2.628 | -2.9 | -2.733 | -3.631 | -1.661 | -40.02 | 0 | 2,754.488 | -14.269 | 23.454 | -3.797 | -5.882 | -2.942 | -1.93 | -2.028 | 174.575 | -121.69 | -85.347 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |